Amgen Inc Drug Patent Portfolio

Amgen Inc's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Amgen Inc News

CVS Health will remove bone disease medications from Amgen and Lilly from select drug lists.

05 Feb, 2026

CVS Health will remove bone disease medications from Amgen and Lilly from certain drug lists - KFGO

05 Feb, 2026

Amgen Acquires Cancer Treatment Company Dark Blue for $840 Million - Bloomberg.com

06 Jan, 2026

Novo Nordisk or Amgen: Which Healthcare Investment Is the Better Option?

23 Dec, 2025

See More